Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

LCI
Lannett Co., Inc.
stock NYSE

At Close
3/24/2023 3:59:55 PM EDT
1.56USD-6.024%(-0.10)26,035
1.54Bid   1.78Ask   0.24Spread IEX
Pre-market
1969-12-31
0.00USD-100.000%(-1.66)0
After-hours
3/23/2023 4:01:49 PM EDT
1.66USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
67.183M
CEO
Timothy Crew
Headquarters
Philadelphia, Pennsylvania, USA
Industry
Drug Manufacturers-Specialty & Generic
Next Earnings
2023-05-03 (39d)
Last Split
2023-02-071for4reverse
Related
AKRXGSKNVSABTJNJPFEMYLXLV
LCI Stats
Avg. Vol. 10 Day
74,123
Avg. Vol. 30 Day
54,055
Employees
564
Market Cap
67,183,373
Shares Out.
43,066,265
P/E Ratio
-0.39
EPS (ttm)
-4.720
On/Off Exchange
51%/49%
6 Month Beta
1.16
1 Year Beta
0.82
2 Year Beta
0.82
3 Year Beta
0.72
52 Week Low
1.54
52 Week High
3.72
SMA50
2.23
SMA200
2.18
1 Week
-5.46%
1 Month
-27.78%
3 Month
-33.11%
6 Month
-18.75%
1 Year
-51.37%
2 Year
-93.40%
5 Year
-97.40%
Jan 27, 2022
06:52AM EST  LANNETT TO REPORT FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE   PR Newswire
Jan 21, 2022
07:39AM EST  Drug maker Lannett Company, Inc. (LCI), said on Friday that the U.S. Food and Drug Administration or FDA has notified the company that it may proceed with its the proposed clinical trials on biosimilar insulin glargine.   RTTNews
07:00AM EST  Lannett Says FDA Completes Review Of IND Application For Biosimilar Insulin Glargine; Stock Surges   RTTNews
06:52AM EST  Lannett Reports FDA Completed Review Of Investigational New Drug Application For Biosimilar Insulin Glargine: 'FDA States Pivotal Clinical Trial May Proceed, Trial Expected to Commence By March 2022'   Benzinga
06:52AM EST  LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND)   PR Newswire
More News
Profile
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

LCI Stock Summary

Lannett Co., Inc. (NYSE:LCI) stock price today is $1.56, and today's volume is 26,035. LCI is down -6.024% today. The 30 day average volume is 54,055. LCI market cap is 67.183M with 43,066,265 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC